Both Eli Lilly $LLY (-1,49%) and Novo Nordisk $NVO (-1,95%) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (-1,49%) is on track to become the first trillion dollar drug-maker...😯